Fig. 9From: Targeting microglial autophagic degradation of the NLRP3 inflammasome for identification of thonningianin A in Alzheimer’s diseaseThe schematic diagram depicts that TA, one of the ellagitannin flavonoids derived from PCP, inhibits the activation of the NLRP3 inflammasome via the AMPK/ULK1- and Raf/MEK/ERK-mediated autophagy in the in vitro and in vivo models of AD, including microglia, C. elegans, and APP/PS1 miceBack to article page